An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

British Journal of Haematology

Volumn 119, Issue 3, 2002, Pages 751-759

  Remberger, Mats ^a   Persson, Ulla ^a   Hauzenberger, Dan ^a   Ringdén, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Graft versus host disease; Haematopoietic stem cell transplant; Human leucocyte antigen

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; HLA B27 ANTIGEN; LEUKOCYTE ANTIGEN; METHOTREXATE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RISK FACTOR; SIBLING; T LYMPHOCYTE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0036433629     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03924.x     Document Type: Article

References (66)

1. Besnier, D.P., Chabannes, D., Mahe, B., Mussini, J.M., Baranger, T.A., Muller, J.Y., Milpied, N. & Esnault, V.L. (1997) Treatment of graft-versus-host disease by extracorporeal photochemotherapy: A pilot study [see comments]. Transplantation, 64, 49-54.
2. Billingham, R. (1966) The biology of graft-versus-host reactions. In: The Harvey Lectures, (ed. by A. Press) Vol. 62, pp. 21-78. Academic Press, New York.
3. Braun, N., Michel, U., Ernst, B.P., Metzner, R., Bitsch, A., Weber, F. & Rieckmann, P. (1996) Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neuroscience Letters, 215, 75-78.
4. Breslow, N.E. & Day, N.E. (1980) Statistical methods in cancer research, Vol. I: The analysis of case- control studies. IARC Scientific Publications, 32, 5-338.
5. Carlens, S., Aschan, J., Remberger, M., Dilber, M. & Ringdén, O. (1999) Low-dose cyclosporin of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukemia. Bone Marrow Transplantation, 24, 629-635.
6. Cavet, J., Middleton, P.G., Segall, M., Noreen, H., Davies, S.M. & Dickinson, A.M. (1999) Recipient tumor necrosis factor-alpha and interleukin 10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood, 94, 3941-3946.
7. Clark, R.E., Hermans, J., Madrigal, A., Nachbaur, D., Kropshofer, G., Gratwohl, A., Apperley, J. & Niederwieser, D. (2001) HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia. British Journal of Haematology, 114, 36-41.
8. Cox, D. (1972) Regression models and life-tables. Journal of the Royal Statistics Society (Series B), 34, 187-220.
9. Ferrara, J.M. (1993) Cytokine dysregulation as a mechanism of graft-versus-host disease. Current Opinions in Immunology, 5, 794-799.
10. Ferrara, J. & Deeg, H. (1991) Graft-versus-host disease. New England Journal of Medicine, 324, 667-674.
11. Gluckman, E., Devergie, A., Poros, A. & Degoulet, P. (1982) Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). British Journal of Haematology, 51, 541-550.
12. Glucksberg, H., Storb, R., Fefer, A., Buckner, C., Neiman, P., Clift, R., Lerner, K. & Thomas, E. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation, 18, 295-304.
13. den Haan, J.M., Sherman, N.E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J.W., Skipper, J., Shabanowitz, J., Hunt, D.F., Engelhard, V.H. & Goulmy, E. (1995) Identification of a graft-versus-host-disease-associated human minor histocompatibility antigen. Science, 268, 1476-1480.
14. Hägglund, H., Ringdén, O., Öhman, S., Remberger, M., Carlens, S. & Mattsson, J. (1998) A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation. Bone Marrow Transplantation, 24, 831-836.
15. Hill, G.R., Krenger, W. & Ferrara, J.L. (1997) The role of cytokines in acute graft-versus-host disease. Cytokines Cell Molecular Therapy, 3, 257-266.
16. Holler, E., Kolb, H., Möller, A., Kempeni, J., Liesenfeld, G., Pechumer, H., Lehmacher, W., Ruckdeschel, G., Gleixner, B., Riedner, C., Ledderose, G., Brehm, G., Mittermuller, J. & Wilmanns, W. (1990) Increased serum levels of tumor necrosis factor alfa precede major complications of bone marrow transplantation. Blood, 75, 1011-1016.
17. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R., Zwaan, F. & Bordin, M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
18. Hymes, S.R., Morison, W.L., Farmer, E.R., Walters, L.L., Tutschka, P.J. & Santos, G.W. (1985) Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. Journal of the American Academy of Dermatology, 12, 30-37.
19. Irlé, C., Salamin, A., Bacigalupo, A., Chapuis, B., Gratwohl, A., Hows, J., Piguet, P. & Grau, G. (1988) Serum TNF levels during graft-versus-host disease after allogenic bone marrow transplantation. Bone Marrow Transplantation, 3, 127.
20. Jacob, C.O., Fronek, Z., Lewis, G.D., Koo, M., Hansen, J.A. & McDevitt, H.O. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosis. Proceedings of the National Academy of Sciences of the United States of America, 87, 1233-1237.
21. Kaplan, E. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistics Association, 53, 457-481.
22. Lanino, E., Lamparelli, T., Dini, G., Alessandrino, E.P., Aversa, F., Calori, E., Medugno, D., Garbarino, L., Locatelli, F., Marenco, P., Mazzola, G., Porta, F., Sacci, N. & Bacigalupo, A. (1993) Bone marrow transplantation from unrelated donors: The Italian experience. GITMO, AIEOP and IBMDR. Bone Marrow Transplantation, 11, 88-89.
23. Lister, J., Messner, H., Keystone, A., Miller, R. & Fritzler, M. (1987) Autoantibody analysis of patients with graft-versus-host disease. Journal of Clinical Laboratory Immunology, 24, 19-23.
24. Marmont, A.M.H.M., Gale, R.P., Sobocinski, K., Ash, R.C., Van Bekkum, D., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S. & Bortin, M.M. (1991) T cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120-2130.
25. Martin, P.J., Schoch, G., Fisher, L., Byers, V., Anasetti, C., Appelbaum, F.R., Beatty, P.G., Doney, K., McDonald, G.B., Sanders, J.E., Sullivan, K., Storb, R., Thomas, E., Witherspoon, R., Lomen, P., Hannigan, J. & Hansen, J.A. (1990) A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood, 76, 1464-1472.
26. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P. & Torok-Storb, B., Yu, C., Blume, K.G. & Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 3390-3400.
27. McSweeney, P.A. & Storb, R. (1999) Mixed chimerism: Preclinical studies and clinical applications. Biological Blood Marrow Transplantation, 5, 192-203.
28. Middleton, P.G., Taylor, P.R., Jackson, G., Proctor, S.J. & Dickinson, A.M. (1998) Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood, 92, 3943-3948.
29. Nedospasov, S.A., Udalova, I.A., Kuprash, D.V. & Turetskaya, R.L. (1991) DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. Journal of Immunology, 147, 1053-1059.
30. Niederwieser, D., Grassegger, A., Aubock, J., Herold, M., Nachbaur, D., Rosenmayr, A., Gachter, A., Nussbaumer, W., Gaggl, S., Ritter, M. & Huber, C. (1993) Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood, 81, 2200-2208.
31. Olerup, O. & Zetterqvist, H. (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens, 39, 225-235.
32. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer, 35, 1-39.
33. Prentice, H.G.B.H., Janossy, G., Gilmore, M.J.M.L., Prince-Jones, L., Tidman, N., Trejdosiewicz, L.K., Skeggs, D.B.L., Panjwani, O., Ball, S., Graphakos, S., Pattersson, J., Ivory, K. & Hoffbrand, A.V. (1984) Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogenic leukemic transplant recipients. Lancet, 1, 472-475.
34. Remberger, M., Ringdén, O. & Markling, L. (1995) TNFa levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. Bone Marrow Transplantation, 15, 99-104.
35. Remberger, M., Aschan, J., Barkholt, L., Tollemar, J. & Ringden, O. Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin. Clinical Transplant, 15, 147-153.
36. Remberger, M., Storer, B., Ringdén, O. & Anasetti, C. (2002) Association between pretransplant thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors. Bone Marrow Transplantation, 29, 391-397.
37. Ringdén, O. & Kersey, J. (1992) Prevention and therapy of graft-versus-host disease. Report from a workshop. Bone Marrow Transplantation, 10, 22-24.
38. Ringdén, O., Båryd, I., Gahrton, G., Groth, C., Johansson, B., Lundgren, G., Lönnqvist, B., Möller, E. & Sundelin, P. (1981) Early treatment and prophylaxis of graft-versus-host disease using prednisolone. Bone Marrow Transplantation, 2, 171-177.
39. Ringdén, O., Baryd, I., Johansson, B., Gahrton, G., Groth, C.G., Lundgren, G. & Lonnqvist, B. (1983) Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. Acta Radiological Oncologica, 22, 423-428.
40. Ringdén, O., Groth, C., Aschan, J., Bolme, B., Ljungman, P., Lönnqvist, B., Malm, G., Månsson, J.-E., Shanwell, A., Svennerholm, L. & Tollemar, J. (1990) Bone marrow transplantation for metabolic disorders at Huddinge hospital. Transplant Proceedings, 22, 198-202.
41. Ringdén, O., Pihlstedt, P., Markling, L., Aschan, J., Båryd, I., Ljungman, P., Lönnqvist, B., Tollemar, J., Janossy, G. & Sundberg, B. (1991) Prevention of graft-versus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplantation, 7, 221-226.
42. Ringdén, O., Horowitz, M. & Sondel, P. (1993a) Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia. Blood, 18, 1094-1101.
43. Ringdén, O., Remberger, M., Aschan, J., Ljungman, P., Lönnqvist, B. & Markling, L. (1993b) Long term follow up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporin in adult leukemic marrow transplant recipients. Transplantation, 58, 887-891.
44. Ringdén, O., Ruutu, T., Remberger, M., Nikoskelainen, J., Volin, L., Vindelöv, L., Parkkali, T., Lenhoff, S., Sallerfors, B., Ljungman, P., Mellander, L., & Jacobsen, N. for the Nordic Bone Marrow Transplantation Group. (1994) A randomized trial comparing busulphan with total body irradiation as conditioning in allogenic marrow transplant recipient with leukemia. Blood, 83, 2723-2730.
45. Ringdén, O., Remberger, M., Persson, U., Ljungman, P., Aldener, A., Andström, E., Aschan, J., Bolme, P., Dahllöf, G., Dalianis, G., Gahrton, G., Hägglund, H., Lönnqvist, B., Olerup, O., Shanwell, A., Sparrelid, E., Winiarski, J., Möller, E. & Öberg, M. (1995) Similar incidence of graft-versus-host disease using HLA-A-B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplantation, 15, 619-625.
46. Ringden, O., Labopin, M., Gluckman, E., Reiffers, J., Vernant, J.P., Jouet, J.P., Harrousseau, J.L., Fiere, D., Bacigalupo, A., Frassoni, F. & Gorin, N.C. (1996) Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporine A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 18, 921-929.
47. Ringrose, J.H. (1999) HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Annals of Rheumatoid Disease, 58, 598-610.
48. Rouquette-Gally, A.M., Boyeldieu, D., Gluckman, E., Abuaf, N. & Combrisson, A. (1987) Autoimmunity in 28 patients after allogeneic bone marrow transplantation: Comparison with Sjogren syndrome and scleroderma. British Journal of Haematology, 66, 45-47.
49. Ruutu, T., Volin, L., Parkkali, T., Juvonen, E. & Elonen, E. (2000) Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: A prospective randomized study. Blood, 96, 2391-2398.
50. Scott, I., O'Shea, J., Bunce, M., Tiercy, J.M., Arguello, R., Firman, H., Goldman, J., Prentice, H.G., Little, A.M. & Madrigal, J.A. (1998) Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: Implications for unrelated bone marrow donor selection. Blood, 92, 4864-4871.
51. Shulman, H., Sullivan, K., Weiden, P., McDonald, G., Striker, G., Sale, G., Hackman, R., Tsoi, M., Storb, R. & Thomas, E. (1980) Chronic graft-versus-host syndrome in man: A clinicopathological study of 20 long-term Seattle patients. American Journal of Medicine, 69, 204-217.
52. Smyth, L.A., Witt, C.S., Christiansen, F.T., Herrmann, R.P., Hollingsworth, P.N., Townend, D.C., Edward, E. & Dawkins, R.L. (1993) The MHC influences acute graft-versus-host disease in MHC-matched adults undergoing allogeneic bone marrow transplantation. Bone Marrow Transplantation, 12, 351-355.
53. Socie, G., Devergie, A., Cosset, J.M., Pierga, J.Y., Esperou, H., Girinski, T. & Gluckman, E. (1990) Low-dose (one Gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease. Transplantation, 49, 657-658.
54. Staszak, C., Goodwin, J.S., Troup, G.M., Pathak, D.R. & Williams, Jr, R.C. (1980) Decreased sensitivity to prostaglandin and histamine in lymphocytes from normal HLA-B12 individuals: A possible role in autoimmunity. Journal of Immunology, 125, 181-185.
55. Storb, R., Prentice, R.L., Buckner, C.D., Clift, R.A., Appelbaum, F., Deeg, J., Doney, K., Hansen, J.A., Mason, M., Sanders, J.E., Singer, J., Sullivan, K.M., Witherspoon, R.P. & Thomas, E.D. (1983a) Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. New England Journal of Medicine, 308, 302-307.
56. Storb, R., Prentice, R.L., Hansen, J.A. & Thomas, E.D. (1983b) Association between HLA-B antigens and acute graft-versus-host disease. Lancet, 2, 816-819.
57. Storb, R., Deeg, H., Pepe, M., Appelbaum, F., Anasetti, C., Beatty, P., Bensinger, W., Berenson, R., Buckner, C.D., Clift, R., Doney, K., Longton, G., Hansen, J., Hill, R., Loughran, Jr, T., Martin, P., Singer, J., Sanders, J., Stewart, P. & Sullivan, K. (1989) Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood, 73, 1729-1734.
58. Stuckey, M.S., Witt, C., Lattimore, M., Warlow, R., Schmitt, L.H. & Dawkins, R.L. (1984) An association between cutaneous sensitivity to histamine and HLA phenotype. Tissue Antigens, 24, 170-173.
59. Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P., Anasetti, C., Loughran, T., Hill, R., Shields, A., Yee, G., Shulman, H., Nims, J., Strom, S. & Thomas, E. (1988) Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood, 72, 555-561.
60. Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, A., Fisher, L., Buckner, C.D., Anasetti, C., Appelbaum, F.R., Badger, C., Beatty, P., Bensinger, W.I., Berenson, R., Bigelow, C., Cheever, M., Clift, R., Deeg, H., Doney, K., Greenberg, P., Hansen, J.A., Hill, R., Loughran, T., Martin, P., Neiman, P., Petersen, F., Sanders, J., Singer, J., Steward, P. & Thomas, E. (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 1720-1728.
61. Takahashi, H., Furukawa, T., Hashimoto, S., Suzuki, N., Kuroha, T., Yamazaki, F., Inano, K., Takahashi, M., Aizawa, Y. & Koike, T. (2000) Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplantation, 26, 1317-1323.
62. Thomas, E., Storb, R., Clift, R., Fefer, A., Johnson, F., Neiman, P., Lerner, K., Glucksberg, H. & Buckner, C. (1975) Bone-marrow transplantation I and II. New England Journal of Medicine, 292, 895-902.
63. Udalova, I.A., Nedospasov, S.A., Webb, G.C., Chaplin, D.D. & Turetskaya, R.L. (1993) Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics, 16, 180-186.
64. Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R. & Thomas, E.D. (1981) Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. New England Journal of Medicine, 304, 1529-1533.
65. Weisdorf, D., Hakke, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J. & Filipovich, A. (1991) Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation, 51, 1197-1203.
66. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. & Duff, G.W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the USA, 94, 3195-3199.